NO307688B1 - Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat - Google Patents

Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat

Info

Publication number
NO307688B1
NO307688B1 NO944287A NO944287A NO307688B1 NO 307688 B1 NO307688 B1 NO 307688B1 NO 944287 A NO944287 A NO 944287A NO 944287 A NO944287 A NO 944287A NO 307688 B1 NO307688 B1 NO 307688B1
Authority
NO
Norway
Prior art keywords
hydrogen
pharmaceutical composition
antihistamine agents
hydroxy
carbon atoms
Prior art date
Application number
NO944287A
Other languages
English (en)
Norwegian (no)
Other versions
NO944287D0 (no
NO944287L (no
Inventor
James Kenneth Woodward
Richard Arthur Okerholm
Mark Gordon Eller
Bruce Edward Mcnutt
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27128589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO307688(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO944287D0 publication Critical patent/NO944287D0/no
Publication of NO944287L publication Critical patent/NO944287L/no
Publication of NO307688B1 publication Critical patent/NO307688B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO944287A 1992-05-11 1994-11-10 Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat NO307688B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88080192A 1992-05-11 1992-05-11
US92289092A 1992-07-31 1992-07-31
PCT/US1993/003151 WO1993023047A1 (en) 1992-05-11 1993-04-06 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient

Publications (3)

Publication Number Publication Date
NO944287D0 NO944287D0 (no) 1994-11-10
NO944287L NO944287L (no) 1994-11-10
NO307688B1 true NO307688B1 (no) 2000-05-15

Family

ID=27128589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944287A NO307688B1 (no) 1992-05-11 1994-11-10 Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat

Country Status (16)

Country Link
US (7) US6037353A (da)
EP (1) EP0639976B1 (da)
JP (1) JPH07506828A (da)
KR (1) KR950701525A (da)
AT (1) ATE194913T1 (da)
AU (1) AU679910B2 (da)
CA (1) CA2134211C (da)
CL (1) CL2004000304A1 (da)
DE (1) DE69320952T2 (da)
DK (1) DK0639976T3 (da)
ES (1) ES2121084T3 (da)
HU (1) HU223774B1 (da)
MX (1) MX9302704A (da)
NO (1) NO307688B1 (da)
NZ (1) NZ251834A (da)
WO (1) WO1993023047A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134211C (en) * 1992-05-11 1999-06-29 James K. Woodward Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
EP1688142A1 (en) * 1992-08-03 2006-08-09 Sepracor Inc. Terfenadine carboxylate and the treatment of dermal irritation
WO1995010278A1 (en) * 1993-10-15 1995-04-20 Hoechst Marion Roussel, Inc. Treatment of allergic disorders with terfenadine carboxylate
IT1271417B (it) * 1993-10-15 1997-05-28 Erregierre Ind Chim Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
EP1178041A1 (en) * 1994-05-18 2002-02-06 Aventis Pharmaceuticals Inc. Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
DK0812195T3 (da) 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
JP4344405B2 (ja) * 1997-08-26 2009-10-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
IL158334A0 (en) * 2001-04-09 2004-05-12 Teva Pharma Polymorphs of fexofenadine hydrochloride
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040044038A1 (en) * 2002-06-10 2004-03-04 Barnaba Krochmal Polymorphic form XVI of fexofenadine hydrochloride
EP1393728A1 (en) * 2002-08-30 2004-03-03 Vrije Universiteit Inverse agonists acting at virus-encoded G protein-coupled receptors
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
JP2007532687A (ja) * 2004-04-26 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド フェキソフェナジン塩酸塩の結晶形およびその製造方法
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
US20090076080A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched fexofenadine
CA2724607A1 (en) * 2008-05-30 2009-12-31 Fairfield Clinical Trials, Llc Method and composition for skin inflammation and discoloration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
CA2134211C (en) * 1992-05-11 1999-06-29 James K. Woodward Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
EP1688142A1 (en) * 1992-08-03 2006-08-09 Sepracor Inc. Terfenadine carboxylate and the treatment of dermal irritation

Also Published As

Publication number Publication date
CL2004000304A1 (es) 2005-05-27
DE69320952D1 (de) 1998-10-15
CA2134211C (en) 1999-06-29
HU223774B1 (hu) 2005-01-28
ATE194913T1 (de) 2000-08-15
KR950701525A (ko) 1995-04-28
NZ251834A (en) 1997-07-27
EP0639976B1 (en) 2000-07-26
AU3973493A (en) 1993-12-13
NO944287D0 (no) 1994-11-10
US20030055083A1 (en) 2003-03-20
US6399632B1 (en) 2002-06-04
US20100168166A1 (en) 2010-07-01
US6187791B1 (en) 2001-02-13
US20030130315A1 (en) 2003-07-10
US20060205782A1 (en) 2006-09-14
JPH07506828A (ja) 1995-07-27
WO1993023047A1 (en) 1993-11-25
CA2134211A1 (en) 1993-11-25
ES2121084T3 (es) 2002-02-16
MX9302704A (es) 1994-06-30
DK0639976T3 (da) 1999-02-15
NO944287L (no) 1994-11-10
HUT71402A (en) 1995-11-28
EP0639976A1 (en) 1995-03-01
DE69320952T2 (de) 1999-05-27
US6037353A (en) 2000-03-14
AU679910B2 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
NO307688B1 (no) Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat
CA2362339A1 (en) Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
BR0010746A (pt) Derivados heterocìclicos úteis com agentes anticâncer
FR2669336B1 (fr) Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FI954609A0 (fi) 1-amidinofenyyli-pyrrolidoneja, -piperidinoneja ja -atsetinoneja verihiutaleiden kasaantumisen inhibiittoreina
DE69415445D1 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
TNSN91056A1 (fr) Derives de benzeneacetamides
ES2091057T3 (es) Composicion medicinal que mejora el metabolismo de los lipidos.
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
ES2148305T3 (es) Derivados de aminoacidos ciclicos que tienen actividad inhibidora de ace y nep.
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
FR2687154B1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
ATE172959T1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
EP0802179A4 (en) DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER
ATE255121T1 (de) Antitumor-indolopyrolocarbazolderivat
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
IT1250626B (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
KR940021526A (ko) 카르복실산 유도체

Legal Events

Date Code Title Description
MK1K Patent expired